Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
16-Time Gold Medalist Paralympic Swimmer Jessica Long and her Goldendoodle Goose Partner with Nulo
-
Clario awarded SAS Global Service Provider Partner of the Year
-
Mindpath Health releases What You Need to Know About Autism
-
INEO Deploys RFID within its INEO Media Network
-
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
-
Lithium Ionic Expands Newly Discovered Zone at Salinas; Drills 1.53% Li2O over 15m, incl. 2.31% Li2O over 8m; 1.15% Li2O over 19m, incl. 1.67% Li2O over 10m, and 1.32% Li2O over 14m
-
SURFER Announces New Editor-in-Chief, Special Edition Print Magazine
-
Cornerstone Building Brands Completes Acquisition of Harvey Building Products; Broadens Exposure to Repair-and-Remodel End Market
-
Montrose Environmental Group Announces Timing of First Quarter 2024 Results
-
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
-
"Godzilla x Kong: The New Empire" released in TrueCut Motion
-
Zilliant Pricing Leader Releases Updated Edition of “Stop Racing In A Blindfold!” Detailing What’s New in the World of Pricing Excellence
-
AI Networking Innovator Nile Expands its Executive Team, Adding Industry Veteran Bill Choi as CFO
-
Revelyst Announces Chief Supply Chain Officer
-
Altair Kicks Off Season Five of the Future Says Podcast
-
BlackSky to Host First Quarter 2024 Results Conference Call
-
Explore Anju's AI Roadmap at the 20th Annual Meeting of ISMPP
-
Corsair Gaming to Report Q1 2024 Financial Results on May 7
-
Mobilicom Launches Groundbreaking OS3 Operations System World’s First for the Drones & Robotics Industry
-
Franchisees from five leading brands share experience and insights at dynamic BELFOR Franchise Group Convention
-
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
-
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
-
hC Bioscience Announces Lead Program in Hemophilia and Reports Positive Preclinical Data on Novel Protein Editing Approach Using Anticodon Engineered tRNA
-
Skye Bioscience to Present at Upcoming Investment Conferences
-
Sapio Sciences Launches New Multimodal Registration Capabilities For Its Lab Informatics Platform
-
TD Bank Group and Aga Khan Museum Renew Collaboration for An Additional Three Years
-
Laser Photonics to Showcase Laser Cleaning Solutions at Upcoming 2024 Offshore Technology Conference
-
Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform
-
Acushnet Holdings Corp. to Announce First Quarter 2024 Financial Results on May 7, 2024
-
Solaris Reports First Drilling Results from 2024 Program and Exploration Update, Including 150m of 0.67% CuEq within 384m of 0.51% CuEq and 284m of 0.53% CuEq from Near Surface
-
Mobilicom Launches Groundbreaking OS3 Operations System World’s First for the Drones & Robotics Industry
-
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
-
Regeneration Biomedical Doses First Patient in a First-in-Human Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brain of Patients with Alzheimer’s Disease
-
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
-
Plug Continues to Make Substantial Advancement in Hydrogen Generation Buildout
-
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma
-
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024
-
Assured Guaranty Ltd. to Report First Quarter 2024 Financial Results on May 7, 2024
-
GXO Renews Agreement with Mars
-
Gen II Expands Presence in the Southeastern United States with New Florida Office
-
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
-
ClickIPO Rebrands Itself as Click Capital Markets
-
Philip Morris International Reports First-Quarter 2024 Results and Updates Full Year Guidance
-
Invesco Reports Results for the Three Months Ended March 31, 2024
-
RTX Reports Q1 2024 Results
-
Ryder Reports First Quarter 2024 Results

